Smad1, β-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription

Development

Volumn 132, Issue 1, 2005, Pages 215-225

  Hu, Ming Chang ^a   Rosenblum, Norman D ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

catenin; Cystogenesis; Myc; Renal dysplasia; Smad1; Tcf4

Indexed keywords

BETA CATENIN; CELL EXTRACT; LUCIFERASE; MYC PROTEIN; SMAD1 PROTEIN; T CELL FACTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL NUCLEUS; CHEMICAL ANALYSIS; CHROMATIN; COMPLEX FORMATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA FLANKING REGION; GENE INTERACTION; GENETIC CODE; KIDNEY CELL; KIDNEY COLLECTING TUBULE; KIDNEY DYSPLASIA; KIDNEY PARENCHYMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; WILD TYPE;

ANIMALS; BETA CATENIN; CELL NUCLEUS; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CYTOSKELETAL PROTEINS; CYTOSOL; DNA-BINDING PROTEINS; KIDNEY; KIDNEY DISEASES; LUCIFERASES; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MUTAGENESIS, SITE-DIRECTED; NERVE TISSUE PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMAD PROTEINS; SMAD1 PROTEIN; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 13444262316     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.01573     Document Type: Article

References (27)

1. Brummelkamp, T. R., Bernards, R. and Agami, R. (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553.
2. Chen, C. R., Kang, Y., Siegel, P. M. and Massague, J. (2002). E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell 110, 19-32.
3. Chichiarelli, S., Coppari, S., Turano, C., Eufemi, M., Altieri, F. and Ferraro, A. (2002). Immunoprecipitation of DNA-protein complexes cross-linked by cis-Diamminedichloroplatinum. Anal. Biochem. 302, 224-229.
4. Cowley, B. D., Jr, Smardo, F. L., Jr, Grantham, J. J. and Calvet, J. P. (1987). Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease. Proc. Natl. Acad. Sci. USA 84, 8394-8398.
5. Dewulf, N., Verschueren, K., Lonnoy, O., Morén, A., Grimsby, S., Vande Spiegle, K., Miyazono, K., Huylebroeck, D. and Ten Dijke, P. (1995). Distinct spatial and temporal expression patterns of two type 1 receptors for bone morphogenetic proteins during mouse embryogenesis. Endocrinology 136, 2652-2663.
6. Frederick, J. P., Liberati, N. T., Waddell, D. S., Shi, Y. and Wang, X. F. (2004). Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol. Cell Biol. 24, 2546-2559.
7. Grandori, C., Cowley, S. M., James, L. P. and Eisenman, R. N. (2000). The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653-699.
8. Grunstein, M. (1997). Histone acetylation in chromatin structure and transcription. Nature 389, 349-352.
9. Gupta, I. R., Piscione, T. D., Grisaru, S., Phan, T., Macias-Silva, M., Zhou, X., Whiteside, C., Wrana, J. L. and Rosenblum, N. D. (1999). Protein Kinase A is a negative regulator of renal branching morphogenesis and modulates inhibitory and stimulatory bone morphogenctic proteins. J. Biol. Chem. 274, 26305-26314.
10. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B. and Kinzler, K. W. (1998). Identification of Myc as a target of the APC pathway. Science 281, 1509-1512.
11. Hu, M. C., Piscione, T. D. and Rosenblum, N. D. (2003). Elevated Smad1/β-catenin molecular complexes and renal medullary cystic dysplasia in ALK3 transgenic mice. Development 130, 2753-2766.
12. Hussein, S. M., Duff, E. K. and Sirard, C. (2003). Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J. Biol. Chem. 278, 48805-48814.
13. Labbe, E., Letamendia, A. and Attisano, L. (2000). Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and Wnt pathways. Proc. Natl. Acad. Sci. USA 97 8358-8363.
14. Miyazaki, Y., Oshima, K., Fogo, A., Hogan, B. L. and Ichikawa, I. (2000). Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J. Clin. Invest. 105, 863-873.
15. Neu, A. M., Ho, P. L., McDonald, R. A. and Warady, B. A. (2002). Chronic dialysis in children and adolescents. The 2001 NAPRTCS Annual Report. Pediatr. Nephrol. 17, 656-663.
16. Nishita, M., Hashimoto, M. K., Ogata, S., Laurent, M. N., Ueno, N., Shibuya, H. and Cho, K. W. (2000). Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature 403, 781-785.
17. Piscione, T. D. and Rosenblum, N. D. (1999). The malformed kidney: disruption of glomerular and tubular development. Clin. Genet. 56, 343-358.
18. Piscione, T. D. and Rosenblum, N. D. (2002). The molecular control of renal branching morphogenesis: current knowledge and emerging insights. Differentiation 70, 227-246.
19. Piscione, T. D., Yager, T. D., Gupta, I. R., Grinfeld, B., Pei, Y., Attisano, L., Wrana, J. L. and Rosenblum, N. D. (1997). BMP-2 and OP-1 exert direct and opposite effects on renal branching morphogenesis. Am. J. Physiol. 273, F961-F975.
20. Pohl, M., Bhatnagar, V., Mendoza, S. A. and Nigam, S. K. (2002). Toward an etiological classification of developmental disorders of the kidney and upper urinary tract. Kidney Int. 61 10-19.
21. Ricker, J. L., Mata, J. E., Iversen, P. L. and Gattone, V. H. (2002). c-myc antisense oligonucleotide treatment ameliorates murine ARPKD. Kidney Int. Suppl. 61, 125-131.
22. Saifudeen, Z., Marks, J., Du, H. and El-Dahr, S. S. (2002). Spatial repression of PCNA by p53 during kidney development. Am. J. Physiol. Renal. Physiol. 283, F727-F733.
23. Saxen, L. (1987). Organogenesis of the Kidney. Cambridge, UK: Cambridge University Press.
24. Trudel, M., Barisoni, L., Lanoix, J. and D'Agati, V. (1998). Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression. Am. J. Pathol. 152, 219-229.
25. Weinmann, A. S., Bartley, S. M., Zhang, T., Zhang, M. Q. and Farnham, P. J. (2001). Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol. Cell Biol. 21, 6820-6832.
26. Weinmann, A. S. and Farnham, P. J. (2002). Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods 26, 37-47.
27. Yagi, K., Furuhashi, M., Aoki, H., Goto, D., Kuwano, H., Sugamura, K., Miyazono, K. and Kato, M. (2002). c-myc is a downstream target of the Smad pathway. J. Biol. Chem. 277, 854-861.